MedPath

Investigating the therapeutic effects of microneedling, TCA 50% and the combination of both in limb vitiligo

Phase 3
Conditions
acral vitiligo.
Vitiligo
Registration Number
IRCT20240204060900N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
21
Inclusion Criteria

Absence of active vitiligo for 2 years
Not receiving treatment in the last 3 months
Lack of sensitivity to the studied drugs
Having at least three depigmented patches at the end of the limb

Exclusion Criteria

Pregnancy and breastfeeding
A history of scar and keloid formation in the body
Received treatment in the last three months
Presence of active vitiligo in the last 2 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath